Rocket


News + Filings
Holdings


All
13F
13D/G
Other

Sarissa Capital Management LP Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 SC 13D/A Sarissa Capital Management LP reports a 5% stake in Alkermes Public Limited Company
06/16/2023 SC 13D/A Sarissa Capital Management LP has filed a Schedule 13D for Alkermes Public Limited Company
06/12/2023 SC 13D/A Sarissa Capital Management LP has filed a Schedule 13D for Alkermes Public Limited Company
06/12/2023 SC 13D/A Sarissa Capital Management LP has filed a Schedule 13D for Alkermes Public Limited Company
05/15/2023 SC 13D/A Sarissa Capital Management LP reports a 10.5% stake in Innoviva, Inc.
02/28/2023 SC 13D/A Sarissa Capital Management LP has filed a Schedule 13D for Amarin Corporation plc
02/27/2023 SC 13D/A Sarissa Capital Management LP has filed a Schedule 13D for Amarin Corporation plc
02/14/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/10/2023 SC 13D/A Sarissa Capital Management LP has filed a Schedule 13D for Amarin Corporation plc
02/08/2023 SC 13D/A Sarissa Capital Management LP reports a 6.2% stake in Amarin Corporation plc
02/06/2023 SC 13D/A Sarissa Capital Management LP reports a 8.5% stake in Alkermes Public Limited Company
01/19/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/10/2023 SC 13D/A Sarissa Capital Management LP reports a 6.2% stake in Amarin Corporation plc
10/11/2022 SC 13D/A Sarissa Capital Management LP reports a 6% stake in Amarin Corporation plc
10/07/2022 SC 13D/A Sarissa Capital Management LP reports a 8.6% stake in Alkermes Public Limited Company
07/06/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/15/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/03/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/10/2022 SC 13D/A Sarissa Capital Management LP reports a 8.7% stake in Alkermes Public Limited Company
11/19/2021 SC 13D/A Sarissa Capital Management LP reports a 8.2% stake in Alkermes Public Limited Company
09/10/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/27/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/25/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/01/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/12/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/14/2020 SC 13D/A Sarissa Capital Management LP reports a 6.3% stake in Innoviva, Inc.
11/09/2020 SC 13D/A Sarissa Capital Management LP has filed a Schedule 13D for Ironwood Pharmaceuticals, Inc.
02/26/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/07/2020 SC 13D/A Sarissa Capital Management LP reports a 0% stake in The Medicines Company
01/02/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/09/2018 SC 13D/A Sarissa Capital Management LP reports a 4.6% stake in Novelion Therapeutics Inc.
06/22/2018 SC 13D/A Sarissa Capital Management LP has filed a Schedule 13D for Apricus Biosciences, Inc.
03/19/2018 SC 13D/A Sarissa Capital Management LP reports a 9.9% stake in Novelion Therapeutics Inc.
01/31/2018 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy